Haneen A Al-Mazroua

发表

Rituximab exerts its anti-arthritic effects via inhibiting NF-κB/GM-CSF/iNOS signaling in B cells in a mouse model of collagen-induced arthritis

A. Nadeem, S. Attia, S. Bakheet, 2023, Heliyon.

DAPTA, a C‐C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T+ Itpr3tf/J mice

A. Nadeem, M. Alshammari, S. Attia, 2019, European journal of pharmacology.

Cadmium exposure exacerbates immunological abnormalities in a BTBR T+ Itpr3tf/J autistic mouse model by upregulating inflammatory mediators in CD45R-expressing cells

A. Nadeem, S. Attia, S. Bakheet, 2023, Journal of Neuroimmunology.

CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T+ Itpr3tf/J mouse model of autism

A. Nadeem, Sheikh F Ahmad, K. E. Ibrahim, 2022, Pharmacology Biochemistry and Behavior.

Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T+ Itpr3tf/J autistic mouse model.

A. Nadeem, S. Attia, M. Algahtani, 2022, Neurotoxicology.

The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T+ Itpr3tf/J mice exposed to gamma rays.

A. Nadeem, Wael A Alanazi, S. Attia, 2019, Molecular immunology.

Cadmium Exposure Is Associated with Behavioral Deficits and Neuroimmune Dysfunction in BTBR T+ Itpr3tf/J Mice

A. Nadeem, S. Attia, M. Alanazi, 2023, International journal of molecular sciences.

A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism

A. Nadeem, S. Attia, S. Bakheet, 2023, Journal of Neuroimmunology.

Methylmercury chloride exposure exacerbates existing neurobehavioral and immune dysfunctions in the BTBR T+ Itpr3tf/J mouse model of autism.

A. Nadeem, K. E. Ibrahim, S. Attia, 2022, Immunology letters.

Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder

A. Nadeem, L. Al-Ayadhi, S. Attia, 2020, Journal of Neuroimmunology.

Involvement of CD45 cells in the development of autism spectrum disorder through dysregulation of granulocyte-macrophage colony-stimulating factor, key inflammatory cytokines, and transcription factors.

A. Nadeem, L. Al-Ayadhi, S. Attia, 2020, International immunopharmacology.

Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance

S. Attia, S. Bakheet, Abdullah A Aldossari, 2023, International journal of molecular sciences.

CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery.

A. Nadeem, N. Ali, S. Attia, 2022, Molecular immunology.

CC chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-γ/IL-10 and STAT4/Smad3 signaling in a mouse model of autoimmune encephalomyelitis.

A. Nadeem, S. Attia, M. Alanazi, 2022, Cellular immunology.

3-Aminobenzamide alleviates elevated DNA damage and DNA methylation in a BTBR T + Itpr3 tf /J mouse model of autism by enhancing repair gene expression

A. Nadeem, S. Attia, S. Bakheet, 2020, Pharmacology Biochemistry and Behavior.

Dysregulation of Ki-67 Expression in T Cells of Children with Autism Spectrum Disorder

A. Nadeem, L. Al-Ayadhi, S. Attia, 2021, Children.

5-Aminoisoquinolinone, a PARP-1 Inhibitor, Ameliorates Immune Abnormalities through Upregulation of Anti-Inflammatory and Downregulation of Inflammatory Parameters in T Cells of BTBR Mouse Model of Autism

A. Nadeem, S. Attia, Khalid Alhazzani, 2021, Brain sciences.

CXCR3 antagonist NBI-74330 mitigates joint inflammation in Collagen-Induced arthritis model in DBA/1J mice.

A. Nadeem, K. E. Ibrahim, S. Attia, 2023, International immunopharmacology.

Downregulation of the Cardiotrophin-1 Gene Expression by Valsartan and Spironolactone in Hypertrophied Heart Rats In Vivo and Rat Cardiomyocyte H9c2 Cell Line In Vitro: A Novel Mechanism of Cardioprotection

H. Korashy, N. Al-Rasheed, H. A. Al-Mazroua, 2013, Journal of cardiovascular pharmacology.

Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice through the inhibition of nuclear factor-kappa B signaling in B cells

A. Nadeem, S. Attia, Khalid Alhazzani, 2023, Brain Research Bulletin.

CXC chemokine receptor 3 antagonist AMG487 shows potent anti-arthritic effects on collagen-induced arthritis by modifying B cell inflammatory profile.

A. Nadeem, H. M. Mahmood, S. Attia, 2020, Immunology letters.

In Silico and In Vivo Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase

M. Rudrapal, Deepak A. Yaraguppi, P. K. Pasala, 2024, Pharmaceuticals.

MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.

A. Nadeem, S. Attia, S. Bakheet, 2023, European journal of pharmacology.

Integrating Blood Biomarkers and Marine Brown Algae-Derived Inhibitors in Parkinson's Disease: A Multi-scale Approach from Interactomics to Quantum Mechanics.

Jency Roshni, Haneen A Al-Mazroua, S. Mahema, 2024, Molecular biotechnology.

Molecular Regulator Driving Endometriosis Towards Endometrial Cancer: A Multi-Scale Computational Investigation to Repurpose Anti-Cancer drugs.

Shiek S. S. J. Ahmed, Jency Roshni, Haneen A Al-Mazroua, 2024, Cell biochemistry and biophysics.

Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder

Metab Alharbi, Abdulrahman Alshammari, Sidharth Mehan, 2022, Brain sciences.